Candida-induced Oral Epithelial Cell Responses

Overview

Journal Mycopathologia

Specialties Microbiology
Pharmacology

Date 2006 Jul 11

PMID 16830188

Citations 5

Authors

E A Lilly

J E Leigh

S H Joseph

P L Fidel Jr

Affiliations

Soon will be listed here.

Abstract

Objective: Oropharyngeal candidiasis (OPC), caused by Candida albicans, is the most common oral infection in HIV(+) persons. Oral epithelial cells are considered important for innate host defense against OPC with production of cytokines in response to C. albicans and the ability to inhibit Candida growth in vitro. The purpose of this study was to determine if Candida similarly induces cytokines by oral epithelial cells from HIV(+) persons, including those with OPC, as well as to determine if cytokines can influence the oral epithelial cell anti-Candida activity.

Methods: Supernatants from oral epithelial cells from HIV(+) persons with and without OPC cultured with Candida were evaluated for cytokines by ELISA, or cytokines were added to the standard growth inhibition assay using epithelial cells from HIV(-) persons.

Results: Results showed low Candida-induced epithelial cell cytokine production from HIV(+) persons, but with some elevated proinflammatory cytokines (TNF-alpha, IL-6) in those with OPC compared to those without OPC. The addition of specific proinflammatory or Th cytokines had no effect on oral epithelial cell anti-Candida activity in healthy HIV(-) persons.

Conclusion: These results suggest that oral epithelial cells from HIV(+) persons can contribute at some level to the oral cytokine milieu in response to Candida during OPC, but that cytokines do not appear to influence oral epithelial cell anti-Candida activity.

Citing Articles

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model.

Wu Y, Jiang L, Zhang L, Liu X, Yan L, Luan T Mycopathologia. 2021; 186(2):177-188.

PMID: 33587236 PMC: 8106589. DOI: 10.1007/s11046-021-00530-8.

Salivary epithelial cells as model to study immune response against cutaneous pathogens.

Negrini T, Arthur R, Waeiss R, Carlosa I, Srinivasan M Clin Transl Sci. 2013; 7(1):48-51.

PMID: 24118988 PMC: 5414475. DOI: 10.1111/cts.12113.

Interplay between Candida albicans and the mammalian innate host defense.

Cheng S, Joosten L, Kullberg B, Netea M Infect Immun. 2012; 80(4):1304-13.

PMID: 22252867 PMC: 3318407. DOI: 10.1128/IAI.06146-11.

Innate immunity including epithelial and nonspecific host factors: workshop 1B.

Weinberg A, Naglik J, Kohli A, Tugizov S, Fidel Jr P, Liu Y Adv Dent Res. 2011; 23(1):122-9.

PMID: 21441493 PMC: 6699119. DOI: 10.1177/0022034511399917.

Activation of ERK-FAK signaling pathway and enhancement of cell migration involved in the early interaction between oral keratinocytes and Candida albicans.

Shi J, Zeng X, Zhou M, Chen Q Mycopathologia. 2008; 167(1):1-7.

PMID: 18612845 DOI: 10.1007/s11046-008-9142-z.

References

Hedges S, Agace W, Svensson M, Sjogren A, Ceska M, Svanborg C . Uroepithelial cells are part of a mucosal cytokine network. Infect Immun. 1994; 62(6):2315-21. PMC: 186514. DOI: 10.1128/iai.62.6.2315-2321.1994. View

Fidel Jr P . Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol. 2002; 40(4):359-75. View

Leigh J, Shetty K, Fidel Jr P . Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS. 2004; 18(8):443-56. DOI: 10.1089/1087291041703665. View

Hedges S, Agace W, Svanborg C . Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 1995; 3(7):266-70. DOI: 10.1016/s0966-842x(00)88941-6. View

Lilly E, Hart D, Leigh J, Hager S, McNulty K, Mercante D . Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis. J Infect Dis. 2004; 190(3):605-12. DOI: 10.1086/422154. View

Xu T, Levitz S, DIAMOND R, Oppenheim F . Anticandidal activity of major human salivary histatins. Infect Immun. 1991; 59(8):2549-54. PMC: 258054. DOI: 10.1128/iai.59.8.2549-2554.1991. View

Gonnella P, Wilmore D . Co-localization of class II antigen and exogenous antigen in the rat enterocyte. J Cell Sci. 1993; 106 ( Pt 3):937-40. DOI: 10.1242/jcs.106.3.937. View

Nomanbhoy F, Steele C, Yano J, Fidel Jr P . Vaginal and oral epithelial cell anti-Candida activity. Infect Immun. 2002; 70(12):7081-8. PMC: 133056. DOI: 10.1128/IAI.70.12.7081-7088.2002. View

Wira C, Rossoll R . Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology. 1995; 136(10):4526-34. DOI: 10.1210/endo.136.10.7664673. View

10.

Salmi M, Jalkanen S . How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol. 1997; 64:139-218. DOI: 10.1016/s0065-2776(08)60889-5. View

11.

Steele C, Ozenci H, Luo W, Scott M, Fidel Jr P . Growth inhibition of Candida albicans by vaginal cells from naïve mice. Med Mycol. 1999; 37(4):251-9. View

12.

Weinberg A, Krisanaprakornkit S, Dale B . Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med. 1998; 9(4):399-414. DOI: 10.1177/10454411980090040201. View

13.

Gonnella P, Neutra M . Membrane-bound and fluid-phase macromolecules enter separate prelysosomal compartments in absorptive cells of suckling rat ileum. J Cell Biol. 1984; 99(3):909-17. PMC: 2113398. DOI: 10.1083/jcb.99.3.909. View

14.

Lehrer R, Ganz T, Szklarek D, Selsted M . Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest. 1988; 81(6):1829-35. PMC: 442632. DOI: 10.1172/JCI113527. View

15.

Brandtzaeg P, Gabrielsen T, Dale I, Muller F, Steinbakk M, Fagerhol M . The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol. 1995; 371A:201-6. DOI: 10.1007/978-1-4615-1941-6_41. View

16.

Steele C, Leigh J, SWOBODA R, Fidel Jr P . Growth inhibition of Candida by human oral epithelial cells. J Infect Dis. 2000; 182(5):1479-85. DOI: 10.1086/315872. View

17.

Steele C, Fidel Jr P . Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002; 70(2):577-83. PMC: 127706. DOI: 10.1128/IAI.70.2.577-583.2002. View

18.

Barousse M, Steele C, Dunlap K, Espinosa T, Boikov D, Sobel J . Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis. 2002; 184(11):1489-93. DOI: 10.1086/324532. View

19.

Steele C, Leigh J, SWOBODA R, Ozenci H, Fidel Jr P . Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells. Infect Immun. 2001; 69(11):7091-9. PMC: 100093. DOI: 10.1128/IAI.69.11.7091-7099.2001. View

20.

Yano J, Lilly E, Steele C, Fortenberry D, Fidel Jr P . Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells. Oral Microbiol Immunol. 2005; 20(4):199-205. PMC: 1361270. DOI: 10.1111/j.1399-302X.2005.00212.x. View